{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:48:32Z","timestamp":1765820912473,"version":"3.48.0"},"reference-count":79,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHMRC Partnership","award":["2019034"],"award-info":[{"award-number":["2019034"]}]},{"name":"Colonial Foundation Trust","award":["1126090"],"award-info":[{"award-number":["1126090"]}]},{"name":"Colonial Foundation Trust","award":["545891"],"award-info":[{"award-number":["545891"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["2023690"],"award-info":[{"award-number":["2023690"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,22]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Supervised injecting facilities (SIFs) are designed to reduce the harms associated with injecting drug use and improve access to health and support services for people who need them. The Supervised Injecting Room Cohort Study (SIRX) aims to provide evidence of the effects, including cost-effectiveness, of a SIF embedded within a community health service, the Melbourne Medically Supervised Injecting Room (MSIR), which has a range of integrated harm reduction, health and social support services on-site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The SIRX study design involves two prospective cohort studies that collect behavioural data and retrospectively and prospectively linked administrative data for primary and tertiary health services, criminal justice records, and mortality. The two cohorts are: (1) participants drawn from the existing Melbourne Injecting Drug User Cohort Study (SuperMIX; established in 2008\u2013ongoing) through which participants consent to annual behavioural surveys (including serological testing for HIV and hepatitis B and C viruses) and linkage to administrative data; and (2) the SIRX-Registration Cohort (SIRX-R; established in 2024) comprising registered MSIR clients who consent to a baseline behavioural survey and administrative data linkage including the frequency of SIF use, and the uptake of on-site services. Primary outcomes are aligned to the legislated aims of the Melbourne MSIR, including ambulance-attended non-fatal overdoses and all-cause and drug-related mortality. Using causal inference methods, analyses will estimate the effect of MSIR exposure (frequent use\/infrequent use\/no use) on these primary outcomes. The SIRX study also has a secondary focus on the effect of MSIR exposure on health service use and related outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>SuperMIX Study (599\/21) and SIRX-R Study (71\/23) ethics approvals were obtained from Alfred Hospital Research Ethics Committee. Participants will be assessed for capacity to provide informed consent following a detailed explanation of the study. Participants are informed of their right to withdraw from the study at any time and that withdrawing does not impact their access to services. Aggregated research results will be disseminated via presentations at national and international scientific conferences and publications in peer-reviewed journals. Local-level reports and outputs will be distributed to key study stakeholders and policymakers. Summary findings via accessible outputs (eg, short infographic summaries) for participants will be displayed in relevant services including the Melbourne MSIR and the study van, and distributed via Harm Reduction Victoria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-091337","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:45:14Z","timestamp":1739277914000},"page":"e091337","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Supervised Injecting Room Cohort Study (SIRX): study protocol"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-3385","authenticated-orcid":false,"given":"Ashleigh C","family":"Stewart","sequence":"first","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-459X","authenticated-orcid":false,"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"Population Health Sciences, University of Bristol, Bristol, UK"},{"name":"National Drug and Alcohol Research Centre, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A","family":"Agius","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"Deakin University Faculty of Health, Burwood, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Scott","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Stone","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8609-0075","authenticated-orcid":false,"given":"Amanda","family":"Roxburgh","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6799-2372","authenticated-orcid":false,"given":"Daniel","family":"O\u2019Keefe","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"Public Health, La Trobe University, Bundoora, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[{"name":"Division of Social Medicine, The University of British Columbia Department of Medicine, Vancouver, British Columbia, Canada"},{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Stoov\u00e9","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne, Fitzroy, Victoria, Australia"},{"name":"Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sione","family":"Crawford","sequence":"additional","affiliation":[{"name":"Harm Reduction Victoria, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Norman","sequence":"additional","affiliation":[{"name":"Centre for Evaluation and Research Evidence, Department of Health Victoria, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Vella-Horne","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Clark","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"The Kirby Institute, Kensington, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dietze","sequence":"additional","affiliation":[{"name":"Disease Elimination, Burnet Institute, Melburne, Victoria, Australia"},{"name":"National Drug Research Institute, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"2025121509450900000_15.2.e091337.1","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"Larney","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025121509450900000_15.2.e091337.2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.12.108282"},{"key":"2025121509450900000_15.2.e091337.3","unstructured":"Chrzanowska A , Man N , Akhurst J , et al . Trends in overdose and other drug-induced deaths in Australia, 2002-2021. Sydney National Drug and Alcohol Research Centre, UNSW Sydney; 2023."},{"key":"2025121509450900000_15.2.e091337.4","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","article-title":"Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review","volume":"11","author":"Degenhardt","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025121509450900000_15.2.e091337.5","unstructured":"Tait R , Allsop S , eds. Quantifying the social costs of pharmaceutical opioid misuse & illicit opioid use to Australia in 2015\/16. Perth, Western Australia: NDRI, 2020."},{"key":"2025121509450900000_15.2.e091337.6","unstructured":"Whetton S , Shanahan M , Cartwright K , et al . The social costs of methamphetamine in Australia 2013\/14. Perth, WA, 2016."},{"key":"2025121509450900000_15.2.e091337.7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12954-015-0057-y","article-title":"Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use","volume":"12","author":"Kirwan","year":"2015","journal-title":"Harm Reduct J"},{"key":"2025121509450900000_15.2.e091337.8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/10826084.2017.1341921","article-title":"Are People Who Inject Drugs Frequent Users of Emergency Department Services? A Cohort Study (2008\u20132013)","volume":"53","author":"Nambiar","year":"2018","journal-title":"Subst Use Misuse"},{"key":"2025121509450900000_15.2.e091337.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014854","article-title":"A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013","volume":"7","author":"Nambiar","year":"2017","journal-title":"BMJ Open"},{"key":"2025121509450900000_15.2.e091337.10","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1016\/S2352-3018(17)30071-1","article-title":"Collateral damage and the criminalisation of drug use","volume":"4","author":"Maher","year":"2017","journal-title":"The Lancet HIV"},{"key":"2025121509450900000_15.2.e091337.11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.drugalcdep.2013.06.026","article-title":"Childhood physical abuse, non-suicidal self-harm and attempted suicide amongst regular injecting drug users","volume":"133","author":"Darke","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"2025121509450900000_15.2.e091337.12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/add.12428","article-title":"The association of childhood physical abuse with the onset and extent of drug use among regular injecting drug users","volume":"109","author":"Darke","year":"2014","journal-title":"Addiction"},{"key":"2025121509450900000_15.2.e091337.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2012.10.015"},{"key":"2025121509450900000_15.2.e091337.14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11524-012-9730-6","article-title":"Housing instability among people who inject drugs: results from the Australian needle and syringe program survey","volume":"90","author":"Topp","year":"2013","journal-title":"J Urban Health"},{"key":"2025121509450900000_15.2.e091337.15","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(21)00013-x"},{"key":"2025121509450900000_15.2.e091337.16","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1093\/ije\/dyab231","article-title":"Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX)","volume":"51","author":"Van Den Boom","year":"2022","journal-title":"Int J Epidemiol"},{"key":"2025121509450900000_15.2.e091337.17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/dar.12881","article-title":"Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study","volume":"38","author":"Winter","year":"2019","journal-title":"Drug Alcohol Rev"},{"key":"2025121509450900000_15.2.e091337.18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"The Lancet"},{"key":"2025121509450900000_15.2.e091337.19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","article-title":"Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis","volume":"391","author":"Aldridge","year":"2018","journal-title":"The Lancet"},{"key":"2025121509450900000_15.2.e091337.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Med"},{"key":"2025121509450900000_15.2.e091337.21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugpo.2017.03.010","article-title":"Frequent emergency department presentations among people who inject drugs: A record linkage study","volume":"44","author":"Nambiar","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2025121509450900000_15.2.e091337.22","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4210-2"},{"key":"2025121509450900000_15.2.e091337.23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12954-023-00773-2","article-title":"Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study","volume":"20","author":"Curtis","year":"2023","journal-title":"Harm Reduct J"},{"key":"2025121509450900000_15.2.e091337.24","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025121509450900000_15.2.e091337.25","unstructured":"European Monitoring Centre for Drugs and Drug Addiction . Perspectives on drugs - drug consumption rooms: an overview of provision and evidence. EMCDDA; 2018."},{"key":"2025121509450900000_15.2.e091337.26","unstructured":"Kerr T , Wood E , Montaner J , et al . Findings from the evaluation of vancouver\u2019s pilot medically supervised safer injection facility\u2014insite (UHRI report). Vancouver, BC BC Centre for Excellence in HIV\/AIDS: Addiction and Urban Health Research Initiative; 2009."},{"key":"2025121509450900000_15.2.e091337.27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2008.05.014","article-title":"Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study","volume":"98","author":"Small","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"2025121509450900000_15.2.e091337.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003351","article-title":"Estimated drug overdose deaths averted by North America\u2019s first medically-supervised safer injection facility","volume":"3","author":"Milloy","year":"2008","journal-title":"PLoS One"},{"key":"2025121509450900000_15.2.e091337.29","first-page":"233","article-title":"The Potential Role for Supervised Injection Facilities in Canada\u2019s Largest City, Toronto","volume":"25","author":"Jozaghi","year":"2015","journal-title":"Int Crim Justice Rev"},{"key":"2025121509450900000_15.2.e091337.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002964","article-title":"Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study","volume":"16","author":"Kennedy","year":"2019","journal-title":"PLoS Med"},{"key":"2025121509450900000_15.2.e091337.31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","article-title":"The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia","volume":"105","author":"Salmon","year":"2010","journal-title":"Addiction"},{"key":"2025121509450900000_15.2.e091337.32","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07312-4"},{"key":"2025121509450900000_15.2.e091337.33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac120"},{"key":"2025121509450900000_15.2.e091337.34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102692","article-title":"Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis","volume":"78","author":"Kennedy","year":"2020","journal-title":"Int J Drug Policy"},{"key":"2025121509450900000_15.2.e091337.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.05.012"},{"key":"2025121509450900000_15.2.e091337.36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","article-title":"Safer injection facility use and syringe sharing in injection drug users","volume":"366","author":"Kerr","year":"2005","journal-title":"The Lancet"},{"key":"2025121509450900000_15.2.e091337.37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugpo.2011.03.003","article-title":"How many HIV infections are prevented by Vancouver Canada\u2019s supervised injection facility?","volume":"22","author":"Pinkerton","year":"2011","journal-title":"Int J Drug Policy"},{"key":"2025121509450900000_15.2.e091337.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.02.018"},{"key":"2025121509450900000_15.2.e091337.39","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.2011.23.5.412"},{"key":"2025121509450900000_15.2.e091337.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2005.04.011"},{"key":"2025121509450900000_15.2.e091337.41","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040774"},{"key":"2025121509450900000_15.2.e091337.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.11.010"},{"key":"2025121509450900000_15.2.e091337.43","doi-asserted-by":"publisher","DOI":"10.1080\/09595230701373818"},{"key":"2025121509450900000_15.2.e091337.44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0955-3959(03)00130-0","article-title":"A comparison of the new Federal Guidelines regulating supervised injection site research in Canada and the Tri-Council Policy Statement on Ethical Conduct for Research Involving Human Subjects","volume":"15","author":"Christie","year":"2004","journal-title":"Int J Drug Policy"},{"key":"2025121509450900000_15.2.e091337.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.04.017"},{"key":"2025121509450900000_15.2.e091337.46","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-017-0154-1","article-title":"Supervised injection facilities in Canada: past, present, and future","volume":"14","author":"Kerr","year":"2017","journal-title":"Harm Reduct J"},{"key":"2025121509450900000_15.2.e091337.47","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"2025121509450900000_15.2.e091337.48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/QAD.0000000000000068","article-title":"Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction","volume":"28","author":"Iversen","year":"2014","journal-title":"AIDS"},{"key":"2025121509450900000_15.2.e091337.49","doi-asserted-by":"crossref","unstructured":"Dwyer R , Power R , Denham G , et al . Public injecting and public amenity in an inner-city suburb of Melbourne, Australia. J Subst Use 2014;162\u20139. doi:10.3109\/14659891.2014.987834","DOI":"10.3109\/14659891.2014.987834"},{"key":"2025121509450900000_15.2.e091337.50","unstructured":"MSIR Review Panel . Review of the MSIR. Melbourne, Victoria State Government of Victoria; 2020."},{"key":"2025121509450900000_15.2.e091337.51","unstructured":"Hawkins J . Finding into death without inquest. Melbourne Victorian Coroner; 2021.1\u201325."},{"key":"2025121509450900000_15.2.e091337.52","unstructured":"Clark N . The role of a medically supervised injecting room in improving access to health and social services. Lisbon, Portugal Lisbon Addictions; 2022."},{"key":"2025121509450900000_15.2.e091337.53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104317","article-title":"Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility","volume":"125","author":"MacIsaac","year":"2024","journal-title":"Int J Drug Policy"},{"key":"2025121509450900000_15.2.e091337.54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/mja2.51885","article-title":"Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility","volume":"218","author":"MacIsaac","year":"2023","journal-title":"Med J Aust"},{"key":"2025121509450900000_15.2.e091337.55","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/dar.13291","article-title":"Initial experience with subcutaneous depot buprenorphine in a medically supervised injecting facility","volume":"40","author":"Weeks","year":"2021","journal-title":"Drug Alcohol Rev"},{"key":"2025121509450900000_15.2.e091337.56","unstructured":"North Richmond Community Health . Medically supervised injecting room. NRCH; 2024. Available: https:\/\/nrch.com.au\/services\/medically-supervised-injecting-room\/"},{"key":"2025121509450900000_15.2.e091337.57","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104213","article-title":"Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility","volume":"121","author":"Whiteside","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2025121509450900000_15.2.e091337.58","unstructured":"MSIR Review Panel . Review of the medically supervised injecting room. Melbourne; 2023."},{"key":"2025121509450900000_15.2.e091337.59","unstructured":"ABC News . Safe injecting room trial extended in North Richmond, new facility slated for near Queen Victoria Market in Melbourne CBD. ABC News; 2020."},{"key":"2025121509450900000_15.2.e091337.60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12954-020-00456-2","article-title":"Supervised consumption sites and crime: scrutinizing the methodological weaknesses and aberrant results of a government report in Alberta, Canada","volume":"18","author":"Livingston","year":"2021","journal-title":"Harm Reduct J"},{"key":"2025121509450900000_15.2.e091337.61","doi-asserted-by":"crossref","first-page":"103856","DOI":"10.1016\/j.regsciurbeco.2022.103856","article-title":"Harm reduction or amplification? The adverse impact of a supervised injection room on housing prices","volume":"98","author":"Liang","year":"2023","journal-title":"Reg Sci Urban Econ"},{"key":"2025121509450900000_15.2.e091337.62","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/dar.13392","article-title":"The print media\u2019s construction of the \u201cdrug problem\u201d in Victorian newspapers: The case of North Richmond Community Health\u2019s medically supervised injecting room","volume":"41","author":"Whiteside","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"2025121509450900000_15.2.e091337.63","unstructured":"Hall B . Flare up as CBD building shortlisted for injecting room site. The Age; 2023."},{"key":"2025121509450900000_15.2.e091337.64","unstructured":"Willingham R , Rollason B . Victorian government scraps plans for a second supervised injecting room in Melbourne. ABC News; 2024."},{"key":"2025121509450900000_15.2.e091337.65","unstructured":"Carey A , Dow A . Victorian liberals to shut down injecting room in a week if elected. The Age; 2018."},{"key":"2025121509450900000_15.2.e091337.66","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-1-9","article-title":"Methodology for evaluating Insite: Canada\u2019s first medically supervised safer injection facility for injection drug users","volume":"1","author":"Wood","year":"2004","journal-title":"Harm Reduct J"},{"key":"2025121509450900000_15.2.e091337.67","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-10-11","article-title":"Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results","volume":"10","author":"Horyniak","year":"2013","journal-title":"Harm Reduct J"},{"key":"2025121509450900000_15.2.e091337.68","unstructured":"MacIsaac M , Whitton B , Anderson J , et al . Rapid point-of-care hepatitis c testing in a medically supervised injecting room. EASL Congress; June 23\u201326, 2021."},{"key":"2025121509450900000_15.2.e091337.69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2025121509450900000_15.2.e091337.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.03.006"},{"key":"2025121509450900000_15.2.e091337.71","unstructured":"Ware JE , Kosinski M , Dewey JE , et al . How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey (with a supplement on the SF-6 health survey). Lincoln, Rhode Island: QualityMetric Incorporated, 2001."},{"key":"2025121509450900000_15.2.e091337.72","unstructured":"International Wellbeing Group . Australian centre on quality of life. Melbourne PWI; 2006."},{"key":"2025121509450900000_15.2.e091337.73","unstructured":"Sax Institute . Secure unified research environment (SURE). Sax Institute; 2024."},{"key":"2025121509450900000_15.2.e091337.74","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00018-3"},{"key":"2025121509450900000_15.2.e091337.75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00001648-199505000-00010","article-title":"The case-time-control design","volume":"6","author":"Suissa","year":"1995","journal-title":"Epidemiology (Sunnyvale)"},{"key":"2025121509450900000_15.2.e091337.76","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal Structural Models and Causal Inference in Epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology (Sunnyvale)"},{"key":"2025121509450900000_15.2.e091337.77","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/aje\/kwx311","article-title":"Analysis of Longitudinal Studies With Repeated Outcome Measures: Adjusting for Time-Dependent Confounding Using Conventional Methods","volume":"187","author":"Keogh","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2025121509450900000_15.2.e091337.78","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1111\/add.15975","article-title":"Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study","volume":"117","author":"Hill","year":"2022","journal-title":"Addiction"},{"key":"2025121509450900000_15.2.e091337.79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12874-024-02377-1","article-title":"Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis","volume":"24","author":"Abdelsalam","year":"2024","journal-title":"BMC Med Res Methodol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-091337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:45:22Z","timestamp":1765820722000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-091337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,11]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-091337"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-091337","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}